Related Experiment Videos
[Benign atheroembolic syndrome secondary to systemic fibrinolysis with streptokinase]
J M García Moreno1, J M Sobrino Márquez, J Elizalde Eguinoa
1Servicio de Medicina Interna, Hospital Juan Ramón Jiménez, Huelva.
Insights
A patient experienced peripheral vascular symptoms, including livedo reticularis, after streptokinase fibrinolysis for myocardial infarction. This led to the amputation of one toe, with successful healing afterward.
Area of Science:
- Cardiology
- Vascular Surgery
Background:
- Acute myocardial infarction requires prompt treatment, often involving fibrinolysis.
- Streptokinase is a common fibrinolytic agent used in managing myocardial infarction.
Observation:
- A 60-year-old male developed peripheral vascular symptoms, including livedo reticularis and pain in the lower body, four days post-myocardial infarction.
- The patient had undergone fibrinolysis with streptokinase for an inferior myocardial infarction.
Findings:
- The patient required symptomatic treatment for the vascular complications.
- Amputation of the fifth right toe was necessary due to the peripheral vascular compromise.
- The patient's condition healed without further organic complications.
Implications:
- This case highlights a rare complication of streptokinase-induced peripheral vascular events.
- Early recognition and management of livedo reticularis post-fibrinolysis are crucial.
- Understanding such adverse events can inform treatment protocols and patient monitoring.
Abstract:
We present the case of an 60-year-old male patient that after a acute myocardial infarction inferior diagnostic was subjected to a fibrinolysis with streptokinase. The evolution from the cardiologic point of view was favourable, but at fourth day postacute myocardial infartion he starts with peripherics vasculars symptoms, pain and livedo reticularis in lower part of the body. A symptomatic treatment was made requiring amputation of his fifth right toe. The evolution was towards healing without any organic afectation at another level.